胰腺铁过载可预测输血依赖型地中海贫血患者内分泌并发症:多中心研究
这项多中心横断面研究纳入994例成年输血依赖型地中海贫血(TDT)患者,用R2*磁共振量化肝、胰、心铁沉积,评估胰腺铁作为内分泌疾病标志物的价值。60.4%患者至少有一种内分泌疾病,胰腺R2*显著更高,且随内分泌严重程度递增。胰腺R2* >80.86 Hz为最佳预测切点,支持将其纳入常规风险分层。
要点
- 胰腺R2* >80.86 Hz是预测TDT患者内分泌疾病的最佳切点。
- 胰腺R2*与心脏R2*存在显著交互作用,共同预测内分泌功能障碍。
- 胰腺铁随内分泌严重程度递增,多内分泌病者最高、无内分泌病者最低。
核心结论
- 胰腺铁过载(R2*)是输血依赖型地中海贫血患者内分泌并发症的可靠标志物,可作为肝外毒性的哨兵指标。
研究设计与样本
- 多中心横断面研究,纳入Extension-Myocardial Iron Overload in Thalassemia网络的994例成年TDT患者(女性53.7%,年龄39.2±8.3岁),用R2*磁共振量化肝、胰、心铁,按标准化临床标准诊断内分泌疾病。
主要发现
- 60.4%患者至少有一种内分泌疾病,有内分泌疾病者胰腺R2*显著高于无内分泌疾病者。
- 多变量回归分析显示年龄、脾切除、胰腺R2*和心脏R2*是内分泌功能障碍的独立预测因素,胰腺与心脏铁存在显著交互作用。
- 胰腺R2* >80.86 Hz是预测内分泌疾病的最佳切点,排除糖尿病患者后胰腺R2*仍为显著预测因素。
- 胰腺铁随内分泌严重程度递增:多内分泌病者最高,单一内分泌病者居中,无内分泌病者最低。
关键数值与推荐
- 胰腺R2* >80.86 Hz为预测内分泌疾病的最佳切点。
- 内分泌疾病包括糖尿病、性腺功能减退、甲状腺功能减退、甲状旁腺功能减退和生长激素缺乏,按标准化临床标准诊断。
临床怎么用
- 可将胰腺R2*测量纳入TDT患者常规风险分层,用于识别内分泌并发症高风险者。
- 胰腺R2* >80.86 Hz提示需加强内分泌疾病筛查,尤其合并心脏铁过载者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This multicentre cross-sectional study evaluated whether pancreatic iron loading could serve as a reliable biomarker for the identification of endocrine disorders in transfusion-dependent thalassaemia (TDT) patients. A total of 994 adult TDT patients (53.7% female; 39.2 ± 8.3 years) from the Extension-Myocardial Iron Overload in Thalassemia network underwent R2* magnetic resonance imaging to quantify hepatic, pancreatic and cardiac iron. Endocrine disorders (diabetes, hypogonadism, hypothyroidism, hypoparathyroidism and growth hormone deficiency) were diagnosed using standardized clinical criteria. Overall, 60.4% of patients had at least one endocrine disorder. Pancreatic R2* was significantly higher in patients with endocrine disorders compared to those without. Multivariable regression analysis identified age, splenectomy, pancreatic R2* and cardiac R2* as independent predictors of endocrine dysfunction, with a significant interaction between pancreatic and cardiac iron. A pancreatic R2* > 80.86 Hz was the best cut-off for predicting endocrine disorders. Pancreatic R2* remained a significant predictor of endocrine disorders even after excluding diabetic patients. Pancreatic iron increased with endocrine severity, being the highest in patients with multiple endocrinopathies, intermediate in those with a single disorder and the lowest in those without endocrine involvement. Pancreatic iron appears to act as a 'sentinel' marker for extra-hepatic toxicity, supporting its integration into routine risk stratification.
引用
- Meloni A, Pistoia L, Longo F, et al. Pancreatic iron overload as a marker of endocrine complications in transfusion-dependent thalassaemia: A multicentre study. Br J Haematol. 2026. PMID: 42747066. doi:10.1111/bjh.70840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。